Testing effectiveness (Phase 2)Study completedNCT00480090
What this trial is testing
A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer
Who this might be right for
Prostate Cancer
University Health Network, Toronto 10